Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies

Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy

(2022) Kerstin Hellwig et al.   JAMA Network Open

Evaluation of Long-term Outcomes Associated With Preterm Exposure to Antenatal Corticosteroids

(2022) Kiran Ninan et al.   JAMA Pediatrics

Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population

(2022) Johanna Balslev Andersen et al.   Multiple Sclerosis and Related Disorders

Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines

(2022) Ruth Dobson et al.   Practical Neurology

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

(2022) Doriana Landi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Use of disease-modifying drugs during pregnancy and breastfeeding

(2021) Ruth Dobson et al.   CURRENT OPINION IN NEUROLOGY

Pregnancy in women with multiple sclerosis in France from 2010 to 2015: Incidence, outcomes, and exposure to disease-modifying therapies

(2021) Hélène Tillaut et al.   Multiple Sclerosis Journal

Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening

(2021) Emilio Portaccio et al.   Multiple Sclerosis Journal

Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients

(2021) Assunta Bianco et al.   Neurotherapeutics

Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists

(2021) Gustavo Saposnik et al.   Multiple Sclerosis and Related Disorders

“I'm walking into the unknown”: Qualitative insights into how emotions and lived experience related to multiple sclerosis diagnosis impact on decisions to pursue disease modifying treatment

(2021) Gina Carey et al.   Multiple Sclerosis and Related Disorders

Interim Analysis of Pregnancy Outcomes After Exposure to Dimethyl Fumarate in a Prospective International Registry

(2021) Kerstin Hellwig et al.   Neurology-Neuroimmunology & Neuroinflammation

First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations

(2020) Per Damkier et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry

(2020) Kerstin Hellwig et al.   JOURNAL OF NEUROLOGY

Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder

(2020) Andrea Ines Ciplea et al.   Neurology-Neuroimmunology & Neuroinflammation

Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions

(2019) Kristen M. Krysko et al.   Neurology-Neuroimmunology & Neuroinflammation

Rebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: Analysis of predisposing factors

(2019) Maria Sepúlveda et al.   Multiple Sclerosis and Related Disorders

Evaluation of glucocorticoid compared with immunoglobulin therapy of severe immune thrombocytopenia during pregnancy: Response rate and complication

(2018) Xue Xu et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

(2018) Xavier Montalban et al.   Multiple Sclerosis Journal

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab

(2018) Emilio Portaccio et al.   NEUROLOGY

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

(2018) Xavier Montalban et al.   Multiple Sclerosis Journal

Adverse Effects of Immunoglobulin Therapy

(2018) Yi Guo et al.   Frontiers in Immunology

Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS

(2018) Maria K. Houtchens et al.   NEUROLOGY

Pregnancy rates and outcomes in women with and without MS in the United States

(2018) Maria K. Houtchens et al.   NEUROLOGY

Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry

(2016) Sandra Thiel et al.   Multiple Sclerosis Journal

Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry

(2016) Sandra Thiel et al.   Multiple Sclerosis Journal

Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis

(2015) Teresa E. Baker et al.   JOURNAL OF HUMAN LACTATION

Sex and gender issues in multiple sclerosis

(2013) Hanne F. Harbo et al.   Therapeutic Advances in Neurological Disorders

Pregnancy outcomes after in utero exposure to Baclofen

(2012) Nathalie Bernard et al.   REPRODUCTIVE TOXICOLOGY